Atlas Trials

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Clinical trial NCT03277352 · TERMINATED

Trial details

NCT number
NCT03277352
Sponsor
Incyte Biosciences International Sàrl
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced MalignanciesMetastatic Cancer
Start date
2017-11-21
Primary completion
2020-07-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.